Penumbra PEN
NYSE PEN
$325.18 +1.42 (+0.44%)
At close: Aug 21, 2026 · 4:00 PM EDT

Penumbra (PEN) Cash & Equivalents (2014 - 2026)

Penumbra (PEN) posted quarterly Cash & Equivalents of $205.3 million for Q2 2026, down 51.33% year-over-year from $421.8 million in Q2 2025, and down 14.93% quarter-over-quarter from $241.3 million in Q1 2026.

Penumbra (PEN) Cash & Equivalents (2014 - 2026) Analysis & Trends

Penumbra (PEN) has reported Cash & Equivalents for 13 consecutive years, with $205.3 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Cash & Equivalents fell 51.33% year-over-year to $205.3 million; the TTM figure through Jun 2026 stood at $205.3 million (down 51.33% YoY), while the FY2025 annual figure was $186.9 million, down 42.39% from the prior year.
  • Cash & Equivalents eased to $205.3 million in Q2 2026 per PEN's latest filing, from $241.3 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $421.8 million in Q2 2025 and bottomed at $54.8 million in Q3 2022.
  • Historically, Cash & Equivalents has averaged $199.8 million across 5 years, with a median of $196.1 million in 2025.
  • Annual changes were most pronounced in 2024 — Cash & Equivalents soared 178.37% — and 2026, when it plunged 51.33%.
  • Penumbra's Cash & Equivalents stood at $69.9 million in 2022, then jumped by 139.75% to $167.5 million in 2023, then soared by 93.69% to $324.4 million in 2024, then plunged by 42.39% to $186.9 million in 2025, then rose by 9.83% to $205.3 million in 2026.
  • Business Quant data shows PEN's Cash & Equivalents at $205.3 million in Q2 2026, $241.3 million in Q1 2026, and $186.9 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn 5.10 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn 3.39 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 1.95 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 539.00 Mn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn 2.91 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 1.11 Bn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn 2.11 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn 3.25 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 482.30 Mn
10 Penumbra 12.80 Bn 12.14 Bn 264.94 Mn 205.27 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 205.27 Mn
Mar 31, 2026 241.29 Mn
Dec 31, 2025 186.90 Mn
Sep 30, 2025 321.03 Mn
Jun 30, 2025 421.77 Mn
Mar 31, 2025 376.05 Mn
Dec 31, 2024 324.40 Mn
Sep 30, 2024 280.48 Mn
Jun 30, 2024 288.33 Mn
Mar 31, 2024 223.11 Mn
Dec 31, 2023 167.49 Mn
Sep 30, 2023 100.76 Mn
Jun 30, 2023 114.17 Mn
Mar 31, 2023 94.69 Mn
Dec 31, 2022 69.86 Mn
Sep 30, 2022 54.84 Mn
Jun 30, 2022 58.23 Mn
Mar 31, 2022 68.16 Mn
Dec 31, 2021 59.38 Mn
Sep 30, 2021 66.29 Mn